In vitro anti-tumour activity of α-galactosylceramide-stimulated human invariant Vα24+NKT cells against melanoma
2001

Anti-tumor activity of NKT cells against melanoma

publication

Author Information

Author(s): Kikuchi A, Nieda M, Schmidt C, Koezuka Y, Ishihara S, Ishikawa Y, Tadokoro K, Durrant S, Boyd A, Juji T, Nicol A

Primary Institution: Department of Research, The Japanese Red Cross Central Blood Center

Hypothesis

Human Vα24+NKT-cells activated by α-GalCer might exhibit anti-tumour activity against human melanoma.

Conclusion

Vα24+NKT-cells stimulated by α-GalCer have anti-tumour activities against human melanoma primarily through soluble mediators.

Supporting Evidence

  • Vα24+NKT-cells did not exhibit cytolytic activity against melanoma cell lines.
  • Proliferation of melanoma cell lines was suppressed by co-culture with activated Vα24+NKT-cells.
  • Culture supernatants from activated Vα24+NKT-cells showed antiproliferative activities against melanoma cells.
  • The inhibitory effects were primarily due to soluble mediators rather than direct cell-to-cell interactions.
  • IFN-γ release was predominantly responsible for the antiproliferative effects.

Takeaway

Scientists found that special immune cells can help fight melanoma by stopping the cancer cells from growing, even though they don't directly kill them.

Methodology

Vα24+NKT-cells were generated from the peripheral blood of patients with melanoma after stimulation with α-GalCer pulsed monocyte-derived dendritic cells.

Participant Demographics

Patients with melanoma.

Digital Object Identifier (DOI)

10.1054/bjoc.2001.1973

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication